Immunothérapie adoptive antivirale après allogreffe de cellules souches hématopoïétiques.

@article{AssiRoth2012ImmunothrapieAA,
  title={Immunoth{\'e}rapie adoptive antivirale apr{\`e}s allogreffe de cellules souches h{\'e}matopo{\"i}{\'e}tiques.},
  author={Lamia A{\"i}ssi-Roth{\'e} and Yingying Wang and V{\'e}ronique Decot and J. F. Stoltz and D. Bensoussan},
  journal={Virologie},
  year={2012},
  volume={16 6},
  pages={
          342-355
        }
}
Viral infections represent one of the main causes of morbidity and mortality following hematopoietic stem cell transplantation. Antiviral treatment failure may be explained by the absence of specific immune reconstitution. In the 1990s, antiviral immunotherapy initially consisting in total donor lymphocyte infusion presented efficiency but was often associated with adverse events. Specific antiviral immunotherapy emerged and relied on the isolation of mono- or multivirus donor-derived-specific… 

References

SHOWING 1-10 OF 51 REFERENCES

Cytotoxic T lymphocytes as immune‐therapy in haematological practice

This review outlines the clinical trials that have been performed, and will describe future initiatives to develop strategies that can increase the breadth of the viruses that can be targeted and simplify the process to extend adoptive transfer of virus‐reactive T cells to more centers so that cellular therapy to reconstitute immunity can be more widely applied.

Infusion of cytomegalovirus (CMV)-specific T cells for the treatment of CMV infection not responding to antiviral chemotherapy.

Anti-CMV cellular therapy was successful in 5 of 7 patients, whereas in 2 of7 patients, who received an intensified immune suppression at the time of or after T-cell therapy, only transient reductions in virus load were obtained.

Adoptive transfer of cytomegalovirus-specific CTL to stem cell transplant patients after selection by HLA–peptide tetramers

A novel approach to adoptive transfer of donor-derived CMV-specific CD8+ T cell clones has considerable potential for antigen-specific T cell therapy.

Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154.

A new strategy to simultaneously select and expand T cells specific for viral and fungal pathogens based on activation-dependent expression of CD154 is investigated, which may form the basis for future adoptive immunotherapy trials in patients at risk for multiple infections.

INFUSION OF CYTOMEGALOVIRUS SPECIFIC CYTOTOXIC T LYMPHOCYTES FROM A SERO-NEGATIVE DONOR CAN FACILITATE RESOLUTION OF INFECTION AND IMMUNE RECONSTITUTION

A stem cell transplant patient with a therapy-refractory cytomegalovirus (CMV) infection who received CMV-specific T cells from his sero-negative stem cell donor is reported, and this strategy could be implemented in similar situations or with persistent viremia post-transplant.

Rapid Generation of Full Clinical-Grade Human Antiadenovirus Cytotoxic T Cells for Adoptive Immunotherapy

Clinical-grade generation of ADV-specific T cells was achieved with a synthetic antigen, which has the advantage of being fast, and is sufficiently reactive to be proposed for immunotherapy if antiviral treatment fails.

Safe adoptive transfer of virus‐specific T‐cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation

In conclusion, induction of a specific T‐cell response through adoptive transfer was feasible and effective, and when performed early in the course of infection, adoptive T‐ cell transfer may protect from HAdV‐related complications.

Clinical-scale generation of human anti-Aspergillus T cells for adoptive immunotherapy

This method of generating functionally active anti-Aspergillus T cells according to good manufacturing practice conditions is suitable for future prospective trials designed to evaluate the effect of adoptive immunotherapy in hematopoietic transplant recipients with invasive aspergillosis.
...